|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 540.29 USD | +0.95% |
|
+7.69% | +15.73% |
| 13/02 | Hca Healthcare Insider Sold Shares Worth $4,126,950, According to a Recent SEC Filing | MT |
| 10/02 | Argus Research Adjusts HCA Healthcare Price Target to $560 From $530, Maintains Buy Rating | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Hospitals and Healthcare Centers | ||||||||||
Operating Hospitals and Related Health Care Entities | 5.88TCr | 6.02TCr | 6.5TCr | 7.06TCr | 7.56TCr | |||||
Total Assets | 5.07TCr | 5.24TCr | 5.62TCr | 5.95TCr | 6.07TCr | |||||
Interest Expense | -156.6Cr | -174.1Cr | -193.8Cr | -206.1Cr | -224.8Cr | |||||
Income Tax Expense | 211.2Cr | 174.6Cr | 161.5Cr | 186.6Cr | 205Cr | |||||
CAPEX | -357.7Cr | -439.5Cr | -474.4Cr | -487.5Cr | -494.4Cr | |||||
EBT | 983.3Cr | 858Cr | 770.6Cr | 852.3Cr | 983.2Cr | |||||
D&A | 285.3Cr | 296.9Cr | 307.7Cr | 331.2Cr | 352.3Cr | |||||
Net Income | 695.6Cr | 564.3Cr | 524.2Cr | 576Cr | 678.4Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
American Group | 2.62TCr | 2.69TCr | 2.23TCr | 2.46TCr | 2.64TCr | |||||
Total Assets | 2.14TCr | 2.22TCr | 1.98TCr | 2.07TCr | 2.12TCr | |||||
D&A | 118.3Cr | 121.9Cr | 97Cr | 108.3Cr | 113.1Cr | |||||
EBITDA | 615.6Cr | 605.5Cr | 520.8Cr | 573.6Cr | 629.6Cr | |||||
Atlantic Group | - | - | 2.12TCr | 2.32TCr | 2.47TCr | |||||
Total Assets | - | - | 1.61TCr | 1.72TCr | 1.79TCr | |||||
D&A | - | - | 99Cr | 106.1Cr | 112.2Cr | |||||
EBITDA | - | - | 449.2Cr | 497.2Cr | 564.2Cr | |||||
National Group | 2.98TCr | 3.04TCr | 1.81TCr | 1.96TCr | 2.13TCr | |||||
Total Assets | 2.12TCr | 2.29TCr | 1.25TCr | 1.29TCr | 1.36TCr | |||||
D&A | 135.9Cr | 146.4Cr | 83Cr | 86Cr | 90Cr | |||||
EBITDA | 720Cr | 637.9Cr | 400Cr | 442.5Cr | 510.3Cr | |||||
Corporate and Other | 277.4Cr | 301.8Cr | 337.8Cr | 321.7Cr | 316.8Cr | |||||
Total Assets | 810.9Cr | 735.9Cr | 784Cr | 877.6Cr | 796.2Cr | |||||
D&A | 31Cr | 29Cr | 28Cr | 31Cr | 36Cr | |||||
EBITDA | -71Cr | -37Cr | -97Cr | -125.1Cr | -147.5Cr |
- Stock Market
- Equities
- HCA Stock
- Financials HCA Healthcare, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition